National Strategy to Support Family Caregivers: Action Guide for Counties
Upcoming Events
Related News
In summer of 2023, NACo partnered with the National Academy of State Health Policy to survey county leaders on the delivery of aging services and supports available to the caregivers of older adults. This action guide highlights those survey findings, the challenges and opportunities for counties and key strategies and recommendations for raising public awareness and improving service delivery for aging adults and their caregivers.
This action guide was made possible by a grant from The John A. Hartford Foundation to the National Academy for State Health Policy in collaboration with the U.S. Administration for Community Living as part of its work implementing the National Strategy to Support Family Caregivers.
For additional information and publications related to the National Strategy to Support Family Caregivers please visit: https://supportcaregiving.org/.
Related News
SAMHSA releases new 2024 data on rates of mental illness and substance use disorder in the U.S.
On July 28, the U.S. Department of Health and Human Services’ (HHS) Substance Abuse and Mental Health Services Administration (SAMHSA) released the findings of its annual National Survey on Drug Use and Health (NSDUH), which provides data on rates of substance use and mental illness at the national, state and local level.
Congress introduces bipartisan legislation to strengthen rural health care access and funding
Rural communities face unique health care challenges, from provider shortages to funding disparities. To address these concerns, the U.S. Senate recently introduced two bipartisan bills aimed at improving rural health care access and funding: the Rural Health Focus Act and the Fair Funding for Rural Hospitals Act.
HALT Fentanyl Act signed into law
On July 16, the Halt All Lethal Trafficking of Fentanyl Act (HALT Fentanyl Act) (P.L. 119-26) was signed into law, marking a major turning point in the nation’s response to the opioid epidemic. The bipartisan legislation permanently classifies fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act, granting law enforcement the authority to combat the growing threat posed by synthetic opioids. The law’s enactment follows years of temporary extensions that placed these substances under federal control on a provisional basis.